Charles River Laboratories International (CRL)
(Delayed Data from NYSE)
$163.12 USD
+1.50 (0.93%)
Updated Feb 4, 2025 04:00 PM ET
After-Market: $163.06 -0.06 (-0.04%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO2/19/25 |
---|---|
Current Quarter | 2.52 |
EPS Last Quarter | 2.59 |
Last EPS Surprise | 6.58% |
ABR | 2.88 |
Earnings ESP
|
-0.60% |
---|---|
Current Year | 10.17 |
Next Year | 10.18 |
EPS (TTM) | 10.12 |
P/E (F1) | 15.88 |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 977.39M | 969.19M | 4.02B | 3.97B |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 990.59M | 985.80M | 4.04B | 4.11B |
Low Estimate | 965.50M | 945.95M | 4.01B | 3.81B |
Year ago Sales | 1.01B | 1.01B | 4.13B | 4.02B |
Year over Year Growth Est. | -3.56% | -4.19% | -2.53% | -1.30% |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.52 | 2.44 | 10.17 | 10.18 |
# of Estimates | 8 | 6 | 9 | 9 |
Most Recent Consensus | 2.46 | 3.10 | NA | 9.40 |
High Estimate | 2.62 | 3.10 | 10.28 | 12.94 |
Low Estimate | 2.45 | 2.16 | 10.10 | 9.38 |
Year ago EPS | 2.46 | 2.27 | 10.67 | 10.17 |
Year over Year Growth Est. | 2.44% | 7.49% | -4.69% | 0.04% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 0 | 1 |
Up Last 60 Days | 0 | 1 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 5 |
Down Last 60 Days | 1 | 2 | 1 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 2.52 | 2.44 | 10.17 | 10.18 |
7 Days Ago | 2.52 | 2.44 | 10.17 | 10.18 |
30 Days Ago | 2.53 | 2.35 | 10.18 | 10.29 |
60 Days Ago | 2.53 | 2.45 | 10.18 | 10.37 |
90 Days Ago | 2.51 | 2.44 | 10.01 | 10.47 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.50 | 2.51 | 10.16 | 10.04 |
Zacks Consensus Estimate | 2.52 | 2.44 | 10.17 | 10.18 |
Earnings ESP | -0.60% | 2.94% | -0.14% | -1.41% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.59 | 2.80 | 2.27 | 2.46 | NA |
Estimate | 2.43 | 2.39 | 2.05 | 2.39 | NA |
Difference | 0.16 | 0.41 | 0.22 | 0.07 | 0.22 |
Surprise | 6.58% | 17.15% | 10.73% | 2.93% | 9.35% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more